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Abstract
Background: In clinical and cohort research, mortality estimates are often derived from manual reports generated
by physicians or electronic reports from vital event registries. We examined the rate of underreporting of deaths by
manual methods as compared with electronic reports from a vital event registry.
Methods: The retrospective analyses included deaths among participants registered in an observational cohort
who initiated highly-active antiretroviral therapy (HAART) between August 1, 1996 and June 30, 2006. Deaths were
routinely reported manually by physicians and through annual electronic record linkages with a population-based
vital event registry. Multivariate logistic regression was carried out to assess independent predictors of death
reporting by manual methods.
Results: Of the 3,116 individuals included in the analyses, 622 (20.0%) died during follow-up. Manual reporting by
physicians only identified 377 (60.6%), while electronic linkages captured 598 (96.1%) of all deaths. Multivariate
analysis indicated that deaths among individuals with lower CD4 cell count, higher HIV plasma viral load, a history
of injection drug use, and under the care of an HIV-experienced physicians were more likely to be reported
manually. Furthermore, non-accidental deaths were more likely to be reported manually, and manual reporting of
deaths increased over time.
Conclusions: Relying only on manual reports to ascertain deaths significantly underestimates the total number of
deaths in the population. This can generate important biases when evaluating the impact of therapeutic
interventions in the populational setting.
Background
Accurate estimates of mortality are necessary for HIV
surveillance, including assessments of antiretroviral treat-
ment programs [1-4]. Several methods can be used to
record deaths in a population, including physician report-
ing, vital statistics, and hospital registries [1,2]. Sampling-
based approaches, verbal autopsies, morgue and burial
data provide additional proxies, particularly in settings
where vital event data may not be available [5-9].
Reporting methods for HIV deaths vary in terms of their
sensitivity and specificity [10-13]. Autopsy and chart
reviews, for example, have better specificity than death
certificates since they describe the underlying causes of
death in detail [3,4]. In clinical and cohort research, mor-
tality estimates are often derived from manual reports gen-
erated by physicians [10] or electronic reports from vital
event registries [14,15]. Previous studies of the HIV-posi-
tive and HIV-negative population have found varying
degrees of agreement between deaths reported manually
by physicians and population census data [16-20].
In this analysis, data derived from a population-based
cohort of HIV-infected individuals on HAART in British
Columbia (BC), Canada, are used to compare the num-
ber of deaths reported manually by physicians to the
number of deaths reported electronically by a vital event
registry.
Methods
This study is based on HIV-positive men and women at
least 18 years of age in the HAART Observational
* Correspondence: bobhogg@cfenet.ubc.ca
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British
Columbia, Canada
Full list of author information is available at the end of the article
Au-Yeung et al. BMC Public Health 2010, 10:642
http://www.biomedcentral.com/1471-2458/10/642
© 2010 Au-Yeung et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Medical Evaluation and Research (HOMER) cohort.
HOMER is a prospective, observation population-based
cohort of individuals enrolled in a province-wide HIV/
AIDS Drug Treatment Program (DTP) in BC, Canada.
The HOMER cohort includes data on individuals who
entered the DTP antiretroviral-naïve to HAART
between August 1, 1996 and June 30, 2006, with follow-
up to June 30, 2007.
The HIV/AIDS DTP and the HOMER cohort have
been approved by the University of British Columbia
(UBC) Research Ethics Board at its St Paul’s Hospital
site. Individuals in HOMER were not required to pro-
vide written informed consent for the purposes of the
analyses presented herein. These administrative analyses
occur within the context of a universal health care sys-
tem in which individuals receive medical care, laboratory
monitoring, and HAART free of charge.
If a death occurs among an individual enrolled in the
DTP, the HAART prescribing and/or primary care phy-
sician is responsible to report the death to the program
(manual reporting). A record linkage between the DTP
and the BC Vital Statistics death registry is also per-
formed annually to capture all deaths among individuals
enrolled in the DTP (electronic reporting). In addition
to these death data, the HOMER cohort captures clini-
cal indicators and socio-demographic information
among individuals enrolled in the DTP.
Analyses included bivariate comparisons of individuals
who died and did not die and multivariate logistic
regression to examine factors associated with manual
methods of reporting deaths among the deceased. The
following covariates were considered in these analyses:
physician practice setting (dichotomized into rural and
urban categories according to Statistics Canada Census
denominations [21,22]); HIV experience among physi-
cians (defined as the number of HIV-positive individuals
the physician had previously treated at the time a
patient was enrolled into the DTP [5]); calendar year of
death, cause of death, age, sex, history of injection drug
use, adherence to HAART (defined as the number of
days of antiretroviral medications dispensed divided by
the number of days of follow-up during first year of
treatment, and expressed as a percent [23]), and baseline
CD4 cell count and HIV plasma viral load. CD4 cell
count was recorded using flow cytometry and fluores-
cent monoclonal antibody analysis (Beckman Coulter,
Inc., Mississauga, Ontario, Canada), and HIV viral load
was measured using the Roche Amplicor Monitor assay
(Roche Diagnostics, Laval, Quebec, Canada) using either
the standard method or the ultrasensitive adaptation.
All analyses are conducted using SAS version 9.1.3
(SAS, Cary, North Carolina, United States). Statistical
tests are two-sided and p-values of less than 0.05 are
considered statistically significant.
Ethical Statement
Ethical approval was requested and obtained for this
study. The HIV/AIDS Drug Treament Program and the
HOMER cohort have been approved by the University
of British Columbia (UBC) Research Ethics Board at its
St Paul’s Hospital site.
Results
Between August 1, 1996 and June 30, 2006, 622 (20.0%)
deaths occurred among the 3,116 individuals in
HOMER. Manual reporting identified 377 (60.6%), while
electronic linkages captured 598 (96.1%) of all deaths.
Manual reporting identified 377 (60.6%), while electro-
nic linkages captured 598 (96.1%) of all deaths. Manual
reporting alone captured only 24 (3.9%) deaths, while
vital statistics alone captured 245 (39.4%) of all deaths.
The remaining 353 (56.8%) deaths were reported by
both sources. Based on a review of the principal cause
of death, the vast majority of deaths (535 [86%]) were
deemed non-accidental (i.e. HIV-related (373 [60%]), cir-
culatory system-related (35 [5.6%]), malignancy-related
(21 [3.4%]), hepatitis-related (19 [3%]), respiratory-
system related (15 [2.4%]), digestive system related
(14 [2.2%]), according to the International Statistical
Classification of Diseases and Related Health Problems
coding system [24]. The remaining 87 (14.0%) deaths
were deemed accidental (i.e. accidental poisoning by and
exposure to noxious substances (60 [9.6%]), intentional
self-harm (16 [2.6%]).
In bivariate analyses, deaths were more likely to occur
among individuals who were older (median age: 41
versus 39; p < 0.001), had a history of injection drug use
(37.3% versus 27.4%; p < 0.001), had a less HIV-experi-
enced physician (median number of HIV-positive
patients: 30 versus 70; p < 0.001), had an AIDS defining
illness at baseline (17.7% versus 14.3%; p = 0.038), had a
lower CD4 cell count at baseline (median CD4: 140
cells/mm
3 versus 200 cells/mm
3; p < 0.001), had a
plasma HIV viral load ≥100,000 copies/mL at baseline
(65.9% versus 53.0%; p < 0.001), and had lower adher-
ence to HAART (61.7% versus 39.2% of patients who
are < 95% adherent to HAART; p < 0.001).
Table 1 shows the results of the multivariate logistic
regression examining factors associated with manual
methods of reporting deaths among the deceased.
Deaths among those with lower CD4 cell count, higher
HIV plasma viral load, a history of injection drug use,
and under the care of an HIV-experienced physician
were more likely to be reported manually. Furthermore,
non-accidental deaths were more likely to be reported
manually, and manual reporting of deaths increased
over time. Of the 245 patients captured by vital statis-
tics, 16 (6.5%) were lost to follow-up (not seen over 6
months) versus 4(1.1%) of the 377 patients captured by
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“not seen in over 12 months”, vital statistics recorded 6
(2.4%) patients versus 1(0.3%) by manual reporting. The
number of deaths captured by vital statistics compared
to manual reporting was still significantly different after
accounting for loss to follow-up (p < 0.05).
Discussion
Our results demonstrate that manual methods of death
reporting by physicians underestimated the total number
of deaths in the population by 40%. Annual electronic
linkages with the vital statistics death registry captured
96% of deaths, suggesting an improved death registry
sensitivity. The remaining 4% of deaths not identified
through this linkage may be attributed to missing data
or discrepancies in the patient identifiers being matched.
While electronic linkages identify a high proportion of
the mortality cases, the disadvantage is that there must
be accurate, up-to-date demographic information such
as names, birthdates, and health care numbers for the
matching process. Even though manual reporting only
covers about 60% of all deaths in our cohort, any patient
identifier discrepancies can be easily clarified with the
physician office staff members.
Our findings are similar to those identified by the
United States Centres for Disease Control, which found
that only 54% of deaths had been manually reported to
the District of Columbia between 2000 and 2005 [17].
In this study, the higher proportion of deaths captured
by electronic methods as compared to manual methods
suggests that electronic record linkage is essential to
accurately ascertain deaths among persons with HIV
[17]. The improved rate of manual reporting in our
study could be a consequence of its longer duration
(1996-2006) and enhanced physician training for manual
reporting over time. Improvements in reporting can
enhance the accuracy of HIV prevalence estimates and
distribution of HIV treatment and prevention resources
in regions with the highest burden [17].
Studies from the United States suggest that underre-
porting may be due to lack of physician knowledge
about the administrative process for reporting deaths,
and intentional non-reporting to protect patient confi-
dentiality [16]. It is promising to note that manually
reporting of deaths has increased over time in our
cohort. Also of interest, HIV-experienced physicians
were more likely to manually report deaths in our study.
This suggests that educational initiatives may be able to
enhance manual death reporting when vital registration
systems are not available or accurate, such as in
resource-limited settings. Additional physician or health
working training for those caring for HIV-infected indi-
viduals may be required to effectively quantify the actual
number of deaths.
Access to vital registration records could be an invalu-
able resource to effectively ascertain the number of
deaths among patients enrolled in a population based
HIV/AIDS treatment program. Cohort studies relying
solely on manually reported data may be significantly
underestimating actual mortality. In addition, patients
r e c o r d e da sl o s tt of o l l o wu pm a yn o tb ec a p t u r e da sa
death by vital registration systems. Thus, this data lim-
itation calls for studies to analyze separate outcomes
based on the time to loss to follow up and the time to
death.
Our study has some strengths and limitations.
Strengths include having a large observational database
and using physician reported data in conjunction with
vital statistics records to obtain socio-demographic and
clinical information on patients. However, the HOMER
cohort provides varying amounts of detail on each
patient’s clinical and socio-demographic characteristics.
Specifically, patient ethnicity was unknown for more
than half of the 622 deaths. Therefore, we were unable
Table 1 Unadjusted and adjusted models showing independent predictors of manual reporting of deaths
Variable Unadjusted Adjusted
OR (95% CI) OR (95% CI)
Physician practice location Urban versus rural 0.79 (0.47 to 1.32) –
Physician HIV-experience per 10 patient increase 1.06 (1.01 to 1.11) 1.02 (1.00 to 1.04)
Year of death per 1 year increase 1.18 (1.11 to 1.26) 1.17 (1.09 to 1.25)
Cause of death Non-accidental versus Accidental 2.23 (1.41 to 3.53) 1.69 (1.03 to 2.78)
Age per 10 year increase 0.99 (0.85 to 1.17) –
Sex Female versus Male 0.84 (0.56 to 1.27) –
History of injection drug use Yes versus No 1.57 (1.12 to 2.20) 1.49 (1.03 to 2.15)
Baseline CD4 cell count (Cells/mm
3) per 100 cells/mm
3
increase
0.88 (0.81 to 0.95) 0.90 (0.83 to 0.98)
Baseline plasma viral load
(Log10 copies/mL)
per Log10 copies/mL increase 1.29 (0.99 to 1.69) 1.38 (1.04 to 1.85)
Adherence ≥ 95% versus < 95% 1.44 (1.03 to 2.02) 1.41 (0.99 to 2.01)
OR, odds ratio; CI, confidence interval.
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deaths reported by physicians and the death registry
stratified by patient ethnicity. Inclusion of this variable
would have been relevant, given that studies in the Uni-
ted States have found disagreement between physician
and vital statistic reporting of deaths by ethnic group
[18-20]. We also realize that confounder variables such
as socio-economic status may have influenced our
results, however, this classification is not made for indi-
viduals in the HOMER cohort.
Conclusion
Our results demonstrate that physicians’ manual HIV
death reports underestimated mortality among indivi-
d u a l so nH A A R Ti nB Cb y4 0 % .C o h o r t sr e l y i n go n l y
on physician reported deaths are potentially underre-
porting the total number of deaths among HIV-
infected individuals. This represents a major limitation
for studies using exclusively physicians’ manual HIV
death reports to ascertain mortality rates, as this prac-
tice can generate important biases when evaluating the
impact of therapeutic interventions in the populational
setting. The use of both manually reported data sys-
tematically cross-checked and supplemented with vital
registration records is ideal for capturing the majority
of deaths in an observational cohort of HIV-infected
patients.
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